Bictegravir is an antiretroviral medication used in combination with other drugs to treat HIV-1 infection. It is classified as an integrase strand transfer inhibitor (INSTI) and works by blocking the enzyme integrase, which is essential for the HIV virus to replicate and integrate into the host cell DNA.
